{"name": "KAI Pharmaceuticals",
 "permalink": "kai-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/kai-pharmaceuticals",
 "homepage_url": "http://www.kaipharmaceuticals.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@kaipharma.com",
 "phone_number": "650-244-1100",
 "description": "",
 "created_at": "Tue Apr 20 12:59:12 UTC 2010",
 "updated_at": "Thu Feb 14 07:03:07 UTC 2013",
 "overview": "\u003Cp\u003EKAI Pharmaceuticals is a drug discovery and development company with multiple, novel clinical-stage programs in the areas of cardiovascular disease, kidney disease and pain. KAI\u00e2\u20ac\u2122s lead product candidate, KAI-9803, is currently in a Phase 2b study (PROTECTION AMI) designed to assess the effect of KAI-9803 on reducing myocardial injury in heart attack patients. KAI\u00e2\u20ac\u2122s second core program, KAI-4169 for the treatment of secondary hyperparathyroidism (SHPT) in kidney disease patients, is expected to enter human clinical trials in 2010. KAI also has an ongoing pain program, KAI-1678, which is currently in Phase 2a testing.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       45],
      "assets/images/resized/0008/4290/84290v1-max-150x150.jpg"],
     [[247,
       75],
      "assets/images/resized/0008/4290/84290v1-max-250x250.jpg"],
     [[247,
       75],
      "assets/images/resized/0008/4290/84290v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Founder / CSO / Scientific Consultant / Chairperson, Scientific Advisory Board Director",
    "person":
     {"first_name": "Daria",
      "last_name": "Mochly-Rosen",
      "permalink": "daria-mochly-rosen",
      "image":
       {"available_sizes":
         [[[127,
            150],
           "assets/images/resized/0025/7887/257887v1-max-150x150.jpg"],
          [[150,
            176],
           "assets/images/resized/0025/7887/257887v1-max-250x250.jpg"],
          [[150,
            176],
           "assets/images/resized/0025/7887/257887v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "member of the boards of directors",
    "person":
     {"first_name": "Paul",
      "last_name": "Sekhri",
      "permalink": "paul-sekhri",
      "image": null}},
   {"is_past": true,
    "title": "Executive Chairman / CEO",
    "person":
     {"first_name": "John",
      "last_name": "Walker",
      "permalink": "john-walker-5",
      "image":
       {"available_sizes":
         [[[127,
            150],
           "assets/images/resized/0025/7886/257886v1-max-150x150.jpg"],
          [[150,
            176],
           "assets/images/resized/0025/7886/257886v1-max-250x250.jpg"],
          [[150,
            176],
           "assets/images/resized/0025/7886/257886v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$35M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.kaipharmaceuticals.com/index.php?option=com_content\u0026task=view\u0026id=36\u0026Itemid=55",
    "source_description": "KAI Pharmaceuticals Completes $35 Million Series B Financing ",
    "raised_amount": 35000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 5,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Investor Growth Capital",
         "permalink": "investor-growth-capital",
         "image":
          {"available_sizes":
            [[[107,
               31],
              "assets/images/resized/0002/9321/29321v1-max-150x150.png"],
             [[107,
               31],
              "assets/images/resized/0002/9321/29321v1-max-250x250.png"],
             [[107,
               31],
              "assets/images/resized/0002/9321/29321v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Aberdare Ventures",
         "permalink": "aberdare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0005/3038/53038v1-max-150x150.jpg"],
             [[250,
               47],
              "assets/images/resized/0005/3038/53038v1-max-250x250.jpg"],
             [[300,
               57],
              "assets/images/resized/0005/3038/53038v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Skyline Ventures",
         "permalink": "skyline-ventures",
         "image":
          {"available_sizes":
            [[[150,
               53],
              "assets/images/resized/0025/1697/251697v1-max-150x150.png"],
             [[250,
               88],
              "assets/images/resized/0025/1697/251697v1-max-250x250.png"],
             [[300,
               106],
              "assets/images/resized/0025/1697/251697v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "InterWest Partners",
         "permalink": "interwest-partners",
         "image":
          {"available_sizes":
            [[[117,
               56],
              "assets/images/resized/0002/9316/29316v1-max-150x150.png"],
             [[117,
               56],
              "assets/images/resized/0002/9316/29316v1-max-250x250.png"],
             [[117,
               56],
              "assets/images/resized/0002/9316/29316v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "InterSouth Partners",
         "permalink": "intersouth-partners",
         "image":
          {"available_sizes":
            [[[150,
               43],
              "assets/images/resized/0002/9315/29315v2-max-150x150.png"],
             [[250,
               71],
              "assets/images/resized/0002/9315/29315v2-max-250x250.png"],
             [[403,
               116],
              "assets/images/resized/0002/9315/29315v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Delphi Ventures",
         "permalink": "delphi-ventures",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0004/5369/45369v1-max-150x150.png"],
             [[206,
               82],
              "assets/images/resized/0004/5369/45369v1-max-250x250.png"],
             [[206,
               82],
              "assets/images/resized/0004/5369/45369v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MDS Capital",
         "permalink": "mds-capital",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 315000000.0,
   "price_currency_code": "USD",
   "term_code": "cash",
   "source_url": "http://www.fiercebiotech.com/story/amgen-snags-kai-pharmas-ckd-program-315m-buyout/2012-04-10",
   "source_description": "UPDATED: Amgen snags KAI Pharma's CKD program in $315M buyout ",
   "acquired_year": 2012,
   "acquired_month": 4,
   "acquired_day": 10,
   "acquiring_company":
    {"name": "Amgen",
     "permalink": "amgen",
     "image":
      {"available_sizes":
        [[[97,
           28],
          "assets/images/resized/0005/9904/59904v1-max-150x150.jpg"],
         [[97,
           28],
          "assets/images/resized/0005/9904/59904v1-max-250x250.jpg"],
         [[97,
           28],
          "assets/images/resized/0005/9904/59904v1-max-450x450.jpg"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "270 Littlefield Avenue",
    "address2": "",
    "zip_code": "94080",
    "city": "South San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        132],
       "assets/images/resized/0008/4291/84291v1-max-150x150.jpg"],
      [[250,
        220],
       "assets/images/resized/0008/4291/84291v1-max-250x250.jpg"],
      [[450,
        396],
       "assets/images/resized/0008/4291/84291v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}